NATCO PHARMA LTD.
BSE: 524816
Shareholding Trends
Ownership split
Institutional detail
Q1 FY27
Corporate Events
Board Meeting
The 43rd Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗Board Meeting
To consider, discuss and decide various matters for the Righ…
BSE Filing ↗Board Meeting
The Board of Directors considered and approved the issuance …
BSE Filing ↗Board Meeting
To consider the Unaudited Financial Results for the quarter …
BSE Filing ↗Board Meeting
The Board of Directors considered and approved an investment…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗Board Meeting
To consider and approve the Scheme of Arrangement for the de…
BSE Filing ↗Board Meeting
Approval of the Audited Financial Results for the quarter an…
BSE Filing ↗Board Meeting
Consideration of Unaudited Financial Results for the quarter…
BSE Filing ↗Board Meeting
consideration and approval of The Unaudited Financial Result…
BSE Filing ↗